- Find out more about our partnerships with ALK Positive, EGFR Resisters, KRAS Kickers, and MET Crusaders.
- See the RFPs for the research we’re funding in 2022.
- Read about the recent FDA approval of nivolumab in combination with chemo for NSCLC and the study published by LCRF Vice Chair Dr. Brendon Stiles.
